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Anti-angiogenic Drug AGM1470 Suppresses Smooth Muscle Cell 
Migration Induced by Endothelial PDGF* 
K. Shigematsut, H. Yasuhara, H. Shigematsu and T. Muto 
Department of Surgery I, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113, Japan 
Objectives: To examine the effects of the anti-angiogenic drug AGM1470 on smooth muscle cell (SMC) migration 
activity stimulated by endothelial cell (EC)-derived mitogen. 
Materials and Methods: Study 1; EC's were cultured under pulsatile flow using MCDB151 medium. From the 
supernatant ofthese EC dishes we devised two types of conditioned medium; anti-PDGF( + ) containing 10 l~g/ml anti- 
PDGF antibody, and anti-PDGF(-) containing no antibody. SMC's were cultured using both media. Study 2; EC's 
were cultured under the same conditions using both types of medium; MCDB151 medium containing 10 ng/ml AGM1470, 
and MCDB151 medium alone. After the AGM1470 concentration had been adjusted to 10 ng/ml, SMC's were cultured 
using each medium; AGM-exposed EC and AGM-non-exposed EC. SMC colony spreading distances were measured as 
an index of mitogenic activity for 4 days. 
Results: Study 1; the anti-PDGF(-) group showed an appparently greater spreading distance than the anti-PDGF( + ) 
group. Study 2; the AGM-non-exposed EC group showed a significantly greater spreading distance than the AGM- 
exposed EC group. However, MTT assay revealed no differences in proliferation between the two groups. 
Conclusion: AGM1470 suppresses the EC production of this PDGF-like mitogen as well as SMC migration activity. 
Key Words: Anastomotic ntimaI hyperplasia; Angiogenesis; AGM1470; Smooth muscle cell; Endothelial cell; Platelet 
derived growth factor. 
Introduction 
Anastomotic ntimal hyperplasia (AIH) following peri- 
pheral grafting is an unsolved problem. Previous tud- 
ies have demonstrated the major mechanisms involved 
in the development of AIH, which are closely related 
to one another. 
The first is overproduction f stimulating humoral 
factors by a variety of cells in the arterial wall, such 
as endothelial cells (EC's), and smooth muscle cells 
(SMC's). In particular, under shear stress, EC pro- 
ductions of prostaglandin I2,1-3 platelet-derived growth 
factor (PDGF), 4'5 basic fibroblastic growth factor 
(bFGF), 5 interleukin-1, 6 and interleukin-6, 6 are stim- 
ulated as compared to the static condition. Notably, 
in contrast to bFGF, PDGF is one of the main mitogens 
for SMC's, and participates in the development of 
* This paper was presented atthe lOth annual meeting of the 
European Society for Vascular Surgery, Venice, Italy (September 
1996). 
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intimal hyperplasia. The second important mechanism 
is uncontrolled proliferation and migration of SMC's 
stimulated by these humoral factors. 7-9 Pathological 
investigations have revealed that he early hyperplastic 
lesion consists of synthetic type SMC's, derived from 
the transformation of contractile type SMC's which 
then migrate from the media to the anastomotic lu- 
minal surface. Recent microscopic studies have also 
demonstrated a third important mechanism. Evidence 
has been reported indicating that the hyperplastic 
lesion is surrounded by new capillaries derived from 
EC's of the host artery, in a process called angio- 
genesis. 1°'11 Thus, EC's may contribute to the de- 
velopment of AIH not only by producing SMC 
mitogens such as PDGF, but also by capillary formation 
which supports the oxygenation and nutrition of SMC. 
Therefore we hypothesised that an angiogenesis 
inhibitor would inhibit AIH by suppressing the stimu- 
lating effects of EC on SMC migration activity as 
well as angiogenesis occurring in proximity to the 
anastomotic sites. To test this hypothesis, we designed 
the present study to investigate the effects of 
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AGM1470, an angiogenesis inhibitor fumagillin ana- 
logue, on SMC migration and proliferation stimulated 
in vitro by exposing EC's to shear stress. 
Materials and Methods 
Cell culture 
EC's were harvested from human umbilical veins by 
an enzyme collagenase method. The primary culture 
and another passage were carried out in MCDB151 
(Sigma, St Louis, MO, U.S.A.) medium supplemented 
with 15% (vol/vol) heat inactivated fetal calf serum 
(Irvine Scientific, Santa Ana, CA, U.S.A.) and 1% L- 
glutamine, all of which were kept in a 37 °C and 5% 
CO2 environment. MCDB151 is the basic powder form 
of the medium, and is suitable for culturing normal 
human cells, such as endothelial and smooth muscle 
cells. The exact composition was previously described 
by Peehl and Ham. 12 SMC's harvested from human 
abdominal aortae (Kurabou, Kurashiki, Japan) were 
prepared, and several passages were also carried out 
under the above mentioned conditions. We used third 
passage EC's and sixth passage SMC's in this study. 
Drugs 
Anti-PDGF BB antibody (Gemzyme, Cambridge, MA, 
U.S.A.), from rabbits, was prepared. This antibody 
specifically binds human PDGF-BB and PDGF-AB and 
demonstrates <11% cross-reactivity with human 
PDGF-AA. 
AGM1470 (O-(chloroacetyl-carbamoyl) fumagillol) 
induced from fumagillin, which is a naturally secreted 
antibiotic of Aspergillus fumigatous, was the generous 
gift of Takeda Chemical Industries, Ltd., Osaka, Japan. 
The structure of this compound was previously pre- 
sented by Irgber et al. 13 
Pulsatile turbulent flow and shear stress loading device 
The rotator (Multishaker MMS-300, Tokyo Rikakikai, 
Tokyo, Japan) was designed to rotate several plastic 
dishes horizontally over a 3.5 cm circumference. Then, 
plastic dishes in which EC's had been cultured were 
placed on the rotating apparatus and rotated. While 
the plastic dishes were thus rotating, medium heights 
in the dishes were changing in an oscillatory fashion, 
Rotation ~-~- -~ Rotation a r 
Fig. 1. Pulsatile turbulent flow and shear stress loading device. 
Plastic dishes in which EC or SMC had been cultured were placed 
on a rotating apparatus and rotated. The surface of the medium 
changes inheight trigonometrically. 
as shown in Fig. 1. With pulsatile changes in the height 
of media, the bottoms of the dishes were exposed to 
pulsatile turbulent flow, which was measured tri- 
gonometrically. Thus, our model induced pulsatile 
turbulent flow in the culture dishes rather than laminar 
flow, produced by cone disk apparatus. 
The haemodynamic analysis in our model is detailed 
in the appendix. Briefly, the medium velocity of point 
A at the bottom of the dish may be approximately as
follows, using the first kind of Bessel function; 
V = K arco3 ~ ,2,- - J12(kr) 
g \/Jl tKr) + 0¢r)2 (1) 
where V is the medium velocity of point A, a is the 
radius of the plastic dish, R is the radius of rotation, 
co is the angular velocity, g is the gravity constant, r 
is the horizontal distance between point A and the 
centre of the dish, and k and K are approximate values 
derived from the velocity potential. Then using the 
boundary layer theory, the shear stress of point A at 
the bottom of the dish can be expressed as follows; 
¢=P V~vV (2) 
where ¢ is the shear stress at the bottom, p is the 
density of the medium, v is the viscosity of the medium. 
In this device, when the EC's and SMC's are exposed 
to rotating movement at speeds of 160 rpm, the ex- 
posed peak shear stress is stimulated in a range from 
18 dyne/cm ~at the edge of the dish to 90 dyne/cm 2 
at the centre of the dish, with mean of 12 dyne/cm ~
and 60 dyne/cm 2, respectively. 
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Measurement ofSMC spreading distance 
We marked a square of side 3 mm using a needle at 
the bottom of a plastic dish 3.5 cm in diameter (Costar, 
Cambridge, MA, U.S.A.). Each dish was coated with 
I ml of type I collagen gel (Cellmatrix type-A kit, Nitta 
gelatin, Osaka, Japan). A silicone plate with a square 
hole of side 3 mm was placed on the collagen gel in 
accordance with the above-mentioned marked square. 
SMCs (3.6 x 103) were put into this hole, and cultured 
in 1 ml of MCDB151 medium containing 15% fetal calf 
serum. The silicone plate was removed after the SMC 
colonies had reached confluence. 
The spreading distance from the baseline of a square 
colony was measured using a microscope, as follows: 
first we focused on the underside of the plastic dish, 
and set the baseline of the objective micrometer at the 
marked line, setting the marked line at the zero point 
of the side. Next, without moving the dish or mi- 
crometer, we focused at the level of the SMC colony. 
Finally, the distance between the zero point and the 
tip of the cell colony was measured on all four sides. 
The spreading distance of the dish was the mean 
distance of the four sides (Fig. 2). 
Study 2: EC-mediated effects of AGM1470 on SMC 
mitogenic activity 
EC's were cultured to confluence in a plastic dish 
3.5 cm in diameter coated with I ml of type I collagen 
gel, and then exposed to the same pulsatile turbulent 
flow for 24h as in Study 1, using both types of 
MCDB151 medium; one containing 10ng/ml of 
AGM1470, the other no AGM1470. After the con- 
centration of AGM1470 in both media had been 
adjusted to 10 ng/ml, we devised two types of con- 
ditioned medium; AGM-exposed EC and AGM-non- 
exposed EC. SMC's of the AGM-exposed EC group 
were cultured in the same plastic dishes using i ml of 
supernatant from the EC dish containing 10 ng/ml of 
AGM1470. SMC's of the AGM-non-exposed EC group 
were cultured using i ml of supernatant from the EC 
dish containing no AGM1470. SMC's cultured in the 
non-conditioned medium - that is, the MCDB151 
medium containing 15% fetal calf serum - served as 
the control Study 2. The microscopic observations 
were made every 24 h for 4 days and SMC spreading 
distances were also measured as an index of mitogenic 
activity. 
Experimental Design 
Study 1: Effects of PDGF derived from EC's under 
pulsatile turbulent flow on SMC mitogenic activity 
EC's were cultured to confluence in a 3.5 cm in dia- 
meter plastic dish coated with I ml of type I collagen 
gel and exposed to pulsatile turbulent flow for 24 h 
as described in the previous section using I ml of 
MCDB151 medium containing 15% fetal calf serum. 
From the supernatant of these EC dishes we devised 
two types of conditioned medium; anti-PDGF(+), 
which contained 10 ~tg/ml anti-PDGF antibody, and 
anti-PDGF(-), which contained no anti-PDGF anti- 
body. SMC's of the anti-PDGF( + ) group were cultured 
in the same plastic dishes using i ml of anti-PDGF( + ) 
medium as described in the previous section on 
measurement of spreading distance. SMC's of the anti- 
PDGF(-) group were cultured in the same plastic 
dishes using i ml of anti-PDGF(-) medium. The non- 
conditioned medium - that is, the MCDB151 medium 
containing 15% fetal calf serum alone - served as 
the control in study 1. We measured SMC spreading 
distance as an index of mitogenic activity in each group 
every 24 h for 4 days using a new model developed in 
our laboratory. 
Statistical Analysis 
All data are presented as means ___ S.D. Statistical ana- 
lysis was carried out using analysis of variance 
(ANOVA) applying post hoc testing using Fisher's pro- 
tected least significant difference t st. Differences were 
considered significant only at a p value below 0.05. 
Results 
Result 1: Effects of PDGF derived from EC's under 
pulsatile turbulent flow on SMC mitogenic activity 
The spreading distance on day 4 was 1865 +185 ~xm 
in the anti-PDGF(+) group, 2285 -+ 306 ~tm in the anti- 
PDGF(-) group, and 1882_+221 ~tm in the non- 
sheared-EC group. There were statistically significant 
differences in spreading distance on day 4 between 
the anti-PDGF( + ) group and the anti-PDGF(- )group 
(p = 0.0034) and between the anti-PDGF(-) group and 
the non-sheared-EC group (p = 0.0047). The spreading 
distance of the anti-PDGF(+) group did not, however, 
differ markedly from that of the non-sheared-EC group 
(Fig. 3). 
Microscopically, SMC's in both the anti-PDGF(-) 
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Type I collagen gel 
After removal 
of the silicone plate 
SMC colony at day 0 
SMC colony at day 4 
RnJrp ~q n x 10 ~) 
Spreading distance = (a + b + c + d)/4 
Fig. 2. Measurements of SMC spreading distance. The spreading distance from the baseline of a square colony was measured using a 
microscope, as follows: (i) we focused on the under-side of the plastic dish, set the baseline of the objective micrometer at the marked 
line, setting the marked line at the zero point of the side. (ii) Without moving the dish or micrometer, we focused at the level of the SMC 
colony. (iii) The distance between the zero point and the tip of the cell colony was measured on all four sides. The spreading distance of 
the dish was the mean distance of the four sides. 
2500 l
_ 2000 
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ho 
1000 
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Anti-PDGF (+) Anti-PDGF (-) Non-conditioned 
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Mean _+ S.D. 
Fig. 3. Effects of PDGF derived from EC's under pulsatile turbulent flow on SMC. There were statistically significant differences in 
migration distance on day 4 between the anti-PDGF( + ) group and tile anti-PDGF(- ) group and between the anti-PDGF(-) group and 
the non-conditioned medium group. Data are expressed as means + S.D. 
* p<0.01. 
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group (p<0.0001) and between the sheared- 
EC(AGM-)  group and the non-sheared-EC group 
(p =0.0007) (Fig. 5). 
Microscopically, both EC's cultured in MCDB151 
medium containing 10ng/ml  AGM1470 and those 
cultured in MCDB151 medium alone showed a cob- 
blestone appearance. There were no apparent mor- 
phological differences between these ECs (Fig. 6). 
To rain±raise the influences of proliferation on the 
spreading distance, we studied proliferative activity 
employing an MTT assay (non-radioactive cell pro- 
liferation assay; CellTiter 96 TM, Promega Corp., Mad- 
ison, WI, U.S.A.) under the same conditions as in 
Study 2. We devised three cell suspension types, each 
2 x 10 s SMC's/ml; SMCs of the AGM-exposed EC 
group, SMC's of the AGM-non-exposed EC group, 
and SMC's of the static EC group. A 100 txl cell sus- 
pension was added to each well of a 96-well plastic 
dishes (Falcon3072, Becton Dickinson and company, 
Lincoln Park, NJ, U.S.A.). The SMC proliferative ac- 
tivity on day 4 was measured using an ELISA reader 
(Model 450 Microplate Reader, BIO-RAD, Hercules, 
CA, U.S.A.). There were no significant differences in 
the corrected absorbance, i.e., the proliferative activity, 
among the three groups (data not shown). 
Fig. 4. The microscopic appearance of SMC'sinfluenced by PDGF 
derived from EC under pulsatile turbulent flow (original mag-
nification x 100). (A) SMC in the anti-PDGF( - ) group and (B) SMC 
in the anti-PDGF(+) group showed a hill and valley appearance 
over all of the colonies. The tips of the colonies in the two groups 
had the same appearance. 
and in the anti-PDGF(+) groups showed a so-called 
hill and valley appearance over all of the colonies, and 
there were no apparent morphological differences in 
SMC's between these groups. (Fig. 4). 
Result 2: EC-mediated effects of AGM1470 on SMC 
mitogenic activity 
The spreading distance on day 4 was 1482 +212 btm 
in the sheared-EC(AGM +) group, 1690 ± 195 btm in 
the sheared-EC(AGM-)  group, and 2048 ± 167 btm in 
the non-sheared-EC group. There were statistically 
significant differences in spreading distance on day 
4 between the sheared-EC(AGM+), group and the 
sheared-EC(AGM-)  group (p = 0.0353), between the 
sheared-EC(AGM+) group and the non-sheared-EC 
Discussion 
Shear loading devices, such as the cone disk type 
a paratus, formerly used for in vitro studies, 14 were 
designed to create the shear stress by means of laminar 
flow. In vivo, however, AIH occurs at sites where the 
flow disturbances result in vortical and oscillating 
flows which place relatively low shear stress loads on 
the lumen. 15 To ensure that our culture conditions 
accurately reflected the in vivo situation, we therefore 
needed to design a new device capable of creating 
pulsative and oscillatory flow. 
In vivo, the estimated shear stress at the femoral 
artery is approximately 10-40 dyne/cm 2,but at arterial 
stenotic sites is apt to rise to at least 500 dyne/cm 2.The 
estimated shear stress in our model is approximately 90
dyne/cm 2 at the peak, with a mean of 60 dyne/cm 2.
These values change trigonometrically and appear to 
be comparable to the shear stress at the heel side of 
the femorodistal bypass anastomosis. Our results may 
reflect the clinical observation that AIH occurs more 
often at sites under the relatively low shear stress, ls'16 
i.e. at the heel side rather than the toe side. 
Although our shear force is consistent with those 
of previously reported values in the laminar flow 
14 experiment, which ranged from 10-100 dyne/cm 2,the 
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Fig. 5. EC-mediated ffects of AGM1470 on SMC mitogenic activity. There were statistically significant differences in migration distance 
on day 4 between the AGM-exposed EC group and the AGM-non-exposed EC group, between the AGM-exposed EC group and the 
non-conditioned medium group and between the AGM-non-exposed EC group and the non-conditioned medium group. Data are 
presented as means + S.D. 
* p<0.01. 
**p<0.05. 
## The final concentration f AGM1470 was adjusted to 10 ng/ml in both the AGM-exposed EC group and the AGM-non-exposed EC
group. 
shear force in our model was pulsatile and turbulent. 
Furthermore, based on in vivo results of the heel side 
of an end-to-side anastomosis, low velocities or flow 
in both directions imultaneously can be interpreted 
as a weak vortex. 17 Therefore, we believe that our 
model has an advantage in that it resembles the clinical 
condition. 
Regardless of the difference in the wave form of 
shear stress, our results are consistent with previous 
data indicating that EC produces PDGF under laminar 
shear stress. 2~ It has also been reported that mRNA 
levels of PDGF B were elevated even at 6 dyne/cm 2 
of shear stress and then declined gradually, reaching 
a minimum at 31 dyne/cm2. TM Elucidation of the in- 
fluences of various types of shear stress awaits further 
investigation. 
The SMC spreading distance was measured as an 
index of mitogenic activity. The measured istance is 
thought o reflect migration and proliferation activities 
of SMC's. Our major assumption is that the de- 
velopment of AIH is influenced by both the migration 
and the proliferation of SMC's .  7 9 Although, with our 
model, it is virtually impossible to differentiate these 
two functional activities, the spreading distance en- 
abled us to assess the overall process of AIH de- 
velopment. In order to assess the correlation between 
the spreading distance and proliferative activity, we 
used an MIT assay which methodologically shows 
proliferative activity alone. This additional study re- 
vealed no significant differences in the proliferative 
activity of SMC's in the AGM-exposed EC and AGM- 
non-exposed EC groups. Therefore, in our ex- 
perimental model, the spreading distance of SMC's 
was considered to reflect migration activity alone. 
It has been demonstrated that angiogenesis plays 
an important role in some pathological conditions, 
such as diabetic retinopathy, arthritis and cancer meta- 
stasis, as well as in the normal process of corpus luteum 
formation and embryonic development. Furthermore, 
angiogenesis was recently reported to contribute to the 
formation of neointimal hyperplasia. 1°'1~ Proliferating 
SMCs may receive nutrition or oxygen via the for- 
mation of new capillaries around the anastomosis. 
However, only a few studies have focused on the 
relation between SMC activity and angiogenesis in 
the formation of AIH. Therefore we examined, albeit 
indirectly, the interaction between SMC mitogenic ac- 
tivity and angiogenesis, both of which EC's participate 
in. Our data suggest that the SMC proliferation is 
regulated by EC-derived PDGF like mitogens under 
the shear stress of oscillatory flow. 
The anti-angiogenic agents, such as AGM1470, are 
well known clinically as anti-angiogenic drugs. 
AGM1470 has been used as an anticancer drug to 
control the growth of malignant cells by inhibiting the 
formation of nutritional capillaries. 13'~9-23 We examined 
the inhibitory effects of AGM1470 on SMC mitogenic 
activity, which was enhanced by EC-derived PDGF. 
Our present data suggest a strong possibility that 
AGM1470 has the potential to inhibit AIH not only 
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Fig. 6. The microscopic appearance of EC's influenced by AGM1470 
(original magnification x100). (A) EC's cultured in MCDB151 
medium containing 10 ng/ml of AGM1470 under pulsatile turbulent 
flow. (B) EC's cultured in MCDB151 medium under pulsatile tur- 
bulent flow. Both EC colonies howed a cobblestone appearance 
and there were no morphological differences between these EC's. 
directly by suppressing SMC migration activity, but 
also indirectly through suppression f EC-derived 
PDGF. To the best of our knowledge, this is the first 
report on the inhibition of SMC mitogenic activity by 
the anti-angiogenesis agent AGM1470. Although mild 
side-effects are expected with the systemic ad- 
ministration of this drug, our in vitro study showed 
clearly that topical application at the anastomosis also 
effectively prevents the SMC's migration and pro- 
liferation which lead to AIH. Furthermore, although 
AGM1470 suppressed the production of PDGF by 
EC's, there were no microscopic morphological 
changes. These data also suggest that long-term topical 
application of AGM1470 is feasible. 
It is well known that there are three PDGF dimer 
types; that is, PDGF-BB, -AB and -AA, and that the 
PDGF-BB and PDGF-AB members of the PDGF family 
have the potential to accelerate mitogenic activity. On 
the other hand, PDGF-AA reportedly does not take 
part in enhancing mitogenic activity. 24'25 The present 
study demonstrated that EC's secrete SMC mitogen 
even under relatively low shear stress, and that this'EC- 
derived SMC mitogen is almost completely neutralized 
and blocked by the anti-PDGF BB antibody. The anti- 
PDGF BB antibody used in this study binds human 
PDGF-BB and PDGF AB specifically, showing less than 
11% cross-reactivity with PDGF-AA. The inhibitory 
effect of anti-PDGF BB antibody indicates that this 
EC-derived mitogen consists mainly of a PDGF-AB or 
-BB like substance. 
In the human body there are several types of cells 
which produce PDGF, such as EC's and platelets. In 
Study 2, AGM1470 exerted a direct inhibitory effect 
on SMC because spreading activity was attenuated 
regardless of the presence of the EC-derived PDGF- 
like substance. This direct effect of AGM1470 may 
also be advantageous for the suppression of the AIH, 
because there are apparently several sources of PDGF 
in the human body. 
In our study, the direct inhibitory effects and the 
indirect effects, through EC, of AGM1470 on SMC 
were demonstrated. However, AGM1470 reportedly 
affects the immune system by stimulating the pro- 
liferation of B lymphocytes through T-lymphocytes. 26 
It is also well known that AIH is affected by T- 
lymphocytes, not nly via the production of inter- 
leukin-1 which stimulates SMC to produce PDGF, but 
also by releasing interferon y, which inhibits SMC 
proliferation. Furthermore, AGM1470 reportedly has 
the potential to inhibit the production of vascular 
endothelial growth factor (VEGF) in rats. 27 We did not, 
however, examine the effects of AGM1470 on EC 
production of VEGF. Taken together with our data, 
these studies suggest hat AGM1470 has the capacity 
to suppress EC humoral activity and SMC mitogenic 
activity, as well as to modulate the immune system, 
in addition to its cytostatic effects on EC's. 
Pharmacokinetic studies using monkeys have 
shown AGM1470 to be metabolised to six metabolites. 2s 
However, the interaction of these metabolites, as re- 
gards the pharmacological effects of AGM1470 in the 
human body, have not been clarified. Therefore, prior 
to AGM1470 being used clinically, detailed studies 
may be needed to determine its metabolic effects. 
In conclusion, the present results demonstrate hat 
the anti-angiogenic drug AGM1470 has the capacity 
to inhibit AIH not only directly, by suppressing SMC 
migration activity, but also indirectly through sup- 
pression of EC-derived PDGF. Furthermore, our data 
indicate that local administration of AGM1470 may 
have beneficial effects in terms of inhibiting neointimal 
hyperplasia. 
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Appendix: Haemodynamic Analysis 
In this device, the shear stress is estimated as follows: 
rz, the vertical velocity of the medium at the dish wall, 
can be expressed as 
the gravity constant. (Fig. 1) Using the formula for the 
velocity potential with the Bessel function, v~ also can 
be expressed as 
aR°93 ~z vz- (1) v~ = = CkJl(kr) cos 0 sinh kz (2) 
g 
where a is the radius of the plastic well, R is the radius where qo is the velocity at point A, 0 is expressed as 
of rotation, co is the rotational radial velocity and g is O-o)t, C is the constant, k is expressed as ji1 ( = 1.814)/ 
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a, r is the horizontal distance between point A and the 
centre of the well, z is the height from the bottom of 
the well to point A. (Fig. 1) 
In the same way, v, the horizontal velocity, can be 
expressed as 
ldr= ~= CkJ'~(kr) cos 0 cosh kz (3) 
Then using (1) and (2), 
1 aRe) 3 
C - (4)  
kJl(ka)sinhkd g 
Then v~ and re, which represents the rotary velocity, 
are expressed as 
1 aRco 3cosh kz , 
vr-jl(ka) g ~ J  ffkr) cos 0 (5) 
1 aRo93 1 ll(kr) o (6) 
V~=ll(ka) g sinhkd kr 
Now, kd is approximated to 0.1, such that cosh kd may 
be approximated to 1 and sinh kd to kd. 
The medium velocity at point A' at the bottom of 
the dish can be expressed as, 
I 
V=K arc03 /ll"2(kr) ' l12(kr) (7) 
where point A' is the up-and-down projection of point 
A. Then using the boundary layer theory, shear stress 
at point A' at the bottom of the well can be ap- 
proximated as follows: 
(8) 
where 0- is the shear stress at the bottom, p is the 
density of the medium, vis the viscosity of the medium. 
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